Treatment of hypertrophic scars and keloids using an intralesional 1470 nm bare-fibre diode laser: a novel efficient minimally-invasive technique
Open Access
- 10 December 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-11
Abstract
Hypertrophic and keloid scars result from abnormal wound healing and can have a variable response to a number of available treatment modalities. The evolution of laser treatments in recent years has shown a wide range of clinical applications including their use in the treatment of scars. We investigated the effectiveness of a 1470 nm diode laser using an intralesional optical fibre delivery device in the treatment of hypertrophic and keloid scars. We evaluated its safety and efficacy as a novel and minimally invasive treatment alternative for scar modulation and volume reduction. A prospective cohort study was performed involving 21 patients with hypertrophic scars (HS) (n = 9) and keloids (n = 12) resulting from various aetiology. Patients were treated with one to three treatment sessions. Comprehensive evaluations were performed using the Vancouver Scar Scale, Doppler ultrasound, Cutometer, Mexameter and PeriCam PSI. Scar thickness was reduced by an average of 0.308 ± 0.138 cm (p < 0.001). In particular the two subgroups showed a significant 27.7% and 28.2% reduction in scar thickness of HS and Keloids, respectively. Scar firmness showed a significant improvement of 1.2% (p < 0.05) for HS, though for keloids this was 0.4% (p = 0.26). Keloids had a significant reduction in pigmentation at 21.3%. Blood perfusion had a significant reduction of 29.6% in HS and 22.7% in Keloids. Overall VSS total score improvement of 42% in the HS and at 37.9% in the Keloid subgroup. No adverse events such as hypo/hyperpigmentation, skin infection, or recurrence were reported. This study shows that the intralesional 1470 nm bare-fibre diode laser significantly improved hypertrophic and keloid scars based on both subjective and objective analyses and supports this type of laser therapy as a safe and effective minimally-invasive treatment option.Keywords
Funding Information
- The National Natural Science Foundation of China (81772098, 81772098)
- Clinical Multi-Disciplinary Team Research Program of 9th People's Hospital, Shanghai Jiao Tong University School of Medicine
- Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant Support
- Clinical Research Program of 9th People's Hospital, Shanghai Jiao Tong University School of Medicine
This publication has 48 references indexed in Scilit:
- A Rare Case of Lymphangioma in the Gluteal Region: Surgical Treatment Combined With Sclerotherapy and Laser TherapyAesthetic Plastic Surgery, 2013
- Hypertrophic scarring of the neck following ablative fractional carbon dioxide laser resurfacingLasers in Surgery and Medicine, 2009
- Hypertrophic Scars and Keloids—A Review of Their Pathophysiology, Risk Factors, and Therapeutic ManagementDermatologic Surgery, 2009
- Histological Evaluation of Artifacts in Tongue Tissue Produced by the CO 2 Laser and the ElectrotomePhotomedicine and Laser Surgery, 2008
- The Diode Laser: A Novel Side-Firing Approach for Laser Vaporisation of the Human Prostate—Immediate Efficacy and 1-Year Follow-UpEuropean Urology, 2007
- Laser treatment of keloids and hypertrophic scarsInternational Journal of Dermatology, 2007
- Endonasal Laser Surgery With a New Laser Fiber Guidance InstrumentThe Laryngoscope, 2000
- The Kinetics of the Thermal Denaturation of Collagen in Unrestrained Rat Tail Tendon Determined by Differential Scanning CalorimetryJournal of Molecular Biology, 1995
- Biochemical Composition of the Connective Tissue in Keloids and Analysis of Collagen Metabolism in Keloid Fibroblast CulturesJournal of Investigative Dermatology, 1985
- Effects of the NdAnnals of Plastic Surgery, 1983